Phase 2 Oesophageal Cancer Clinical Trials
14 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–14 of 14 trials
Recruiting
Phase 2
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
Breast CancerColorectal, CancerEsophageal Cancer+9 more
Jazz Pharmaceuticals200 enrolled28 locationsNCT06695845
Recruiting
Phase 2
BEFAST Study, [68Ga]Ga-FAPI Total Body PET/CT for Better and Faster Imaging in Cancer
Gastroesophageal Cancer (GC)Pancreatic Cancer, Adult
Barbara Malene Fischer90 enrolled1 locationNCT07629609
Recruiting
Phase 1Phase 2
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
Breast CancerEsophageal CancerPancreatic Cancer+13 more
ModeX Therapeutics, An OPKO Health Company285 enrolled6 locationsNCT06239194
Recruiting
Phase 2
Neratinib In Combination With Chemotherapy/Trastuzumab/Pembrolizumab In HER2 Gastroesophageal Cancer
Gastric CancerGastroesophageal Cancer
H. Lee Moffitt Cancer Center and Research Institute36 enrolled1 locationNCT06109467
Recruiting
Phase 2
Synergistic Effects of PD-1 Antibody and Chemotherapy/Targeted Therapy Followed by Surgery-centric Local Treatment in Patients With Limited-metastatic Gastric Cancer
Gastric CancerGastroesophageal Cancer
Shanghai Zhongshan Hospital84 enrolled2 locationsNCT06468280
Recruiting
Phase 2
Clinical Study of Adbelimumab in the Adjuvant Treatment of Esophageal Squamous Cell Carcinoma.
Squamous Oesophageal Cancer
Hebei Medical University Fourth Hospital142 enrolled1 locationNCT07266480
Recruiting
Phase 2
Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma
Gastric CancerGastroesophageal CancerAdenocarcinoma
Harry H Yoon58 enrolled2 locationsNCT04069273
Recruiting
Phase 2
PULSO Trial: Pulsed Low-Dose-Rate (PLDR) Radiation Chemoradiation (CRT) vs. Standard CRT for Esophageal Cancer
Esophageal CancerGastroesophageal CancerOesophageal Cancer
Medical College of Wisconsin50 enrolled1 locationNCT06906887
Recruiting
Phase 2Phase 3
Total Neoadjuvant FLOT Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer
Gastric CancerChemotherapyGastroesophageal Junction Adenocarcinoma+13 more
Ukrainian Society of Clinical Oncology150 enrolled2 locationsNCT06028737
Recruiting
Phase 2Phase 3
Multicenter Validation Trial of [18F]AlF-FAPI-74 for PET Imaging of Cancer-associated Fibroblasts Through Fibroblast Activation Protein Inhibitors (FAPI) in Different Tumor Types
Gastric CancerPancreatic Ductal AdenocarcinomaOncology+3 more
KU Leuven109 enrolled3 locationsNCT06782412
Recruiting
Phase 2
A Value-Driven Study on Reducing Immune Checkpoint Inhibitor Dosing Frequency in Advanced Cancers
Non-small Cell Lung CancerHead and Neck Squamous Cell CarcinomaCarcinoma, Hepatocellular+3 more
National University Hospital, Singapore360 enrolled1 locationNCT06422403
Recruiting
Phase 2
Developing ctDNA Guided Adjuvant Therapy for Gastrooesophageal Cancer
Gastrooesophageal Cancer
University of Southampton25 enrolled14 locationsNCT05965479
Recruiting
Phase 2
A trial of palliative chemotherapy, Radiation and immune treatment for Oesophageal Cancer: PALEO Study
Oesophageal Cancer
Australasian Gastro-Intestinal Cancer Trials Group54 enrolled2 locationsACTRN12619001371189
Recruiting
Phase 2
Does the use of nizatidine (Tazac) as a prokinetic agent improve gastric emptying in patients who have had an oesophagectomy for oesophageal cancer?
Delayed gastric emptying post oesophagectomy for oesophageal cancer
Cabrini Clinical Education and Research Institute20 enrolled1 locationACTRN12605000454673